Masahiro Yasui

842 total citations
40 papers, 404 citations indexed

About

Masahiro Yasui is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Masahiro Yasui has authored 40 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 11 papers in Public Health, Environmental and Occupational Health and 10 papers in Oncology. Recurrent topics in Masahiro Yasui's work include Hematopoietic Stem Cell Transplantation (10 papers), Acute Lymphoblastic Leukemia research (9 papers) and Viral-associated cancers and disorders (8 papers). Masahiro Yasui is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Acute Lymphoblastic Leukemia research (9 papers) and Viral-associated cancers and disorders (8 papers). Masahiro Yasui collaborates with scholars based in Japan, Iran and United Kingdom. Masahiro Yasui's co-authors include Masami Inoue, Keisei Kawa, Akihisa Sawada, Osamu Kondo, Takayuki Okamura, Emiko Sato, Toshihiko Imamura, Akira Morimoto, Yoko Shioda and Kazuko Kudo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of General Virology.

In The Last Decade

Masahiro Yasui

38 papers receiving 398 citations

Peers

Countries citing papers authored by Masahiro Yasui

Since Specialization

Citations

This map shows the geographic impact of Masahiro Yasui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Yasui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Yasui more than expected).

Fields of papers citing papers by Masahiro Yasui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiro Yasui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Yasui. The network helps show where Masahiro Yasui may publish in the future.

Co-authorship network of co-authors of Masahiro Yasui

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Yasui. A scholar is included among the top collaborators of Masahiro Yasui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Yasui. Masahiro Yasui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Short-term and long-term outcomes of patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis 2024 ·Lara D. Veeken ·(unknown), Shunsuke Furuta, Michio Fujiwara, Masaki Hiraguri, Koichi Hirose, Kei Ikeda, Taro Iwamoto, Shin‐ichiro Kagami, Y Kobayashi, Kazuhiro Kurasawa, Daiki Nakagomi, Yoshihiro Oya, (unknown), Toshimasa Shimizu, Tomohiro Tamachi, Takeshi Umibe, Masahiro Yasui, Hiroshi Nakajima	3
2	Fulminant myocarditis with adult-onset Still’s disease: case-based review 2023 ·Clinical Rheumatology ·Ryohei Ono, (unknown), (unknown), (unknown), Hirotoshi Kato, (unknown), Masahiro Yasui, (unknown), Shunsuke Furuta, Hiroshi Nakajima, Yoshio Kobayashi	5
3	New therapies in anti-MDA5 antibody-positive dermatomyositis 2023 ·Current Opinion in Rheumatology ·Masahiro Yasui, Taro Iwamoto, Shunsuke Furuta	5
4	Prognostic Factors for Outcomes of Allogeneic HSCT for Children and Adolescents/Young Adults With CML in the TKI Era 2022 ·Transplantation and Cellular Therapy ·Hiroyuki Shimada, Akihiko Tanizawa, Takeshi Kondo, Tokiko Nagamura‐Inoue, Masahiro Yasui, Arinobu Tojo, Hideki Muramatsu, Tetsuya Eto, Noriko Doki, Masatsugu Tanaka, Maho Sato, Maiko Noguchi, Naoyuki Uchida, Yoshiyuki Takahashi, Naoki Sakata, Tatsuo Ichinohe, Yoshiko Hashii, Koji Kato, Yoshiko Atsuta, Kazuteru Ohashi	3
5	Radiation-sparing reduced-intensity unrelated umbilical cord blood transplantation for rare hematological disorders in children 2021 ·International Journal of Hematology ·Akihisa Sawada, (unknown), (unknown), (unknown), Yosuke Okada, (unknown), (unknown), Masahiro Yasui, Masami Inoue	0
6	High rates of ovarian function preservation after hematopoietic cell transplantation with melphalan-based reduced intensity conditioning for pediatric acute leukemia: an analysis from the Japan Association of Childhood Leukemia Study (JACLS) 2019 ·International Journal of Hematology ·Hisanori Fujino, Hiroyuki Ishida, Akihiro Iguchi, (unknown), Koji Kato, (unknown), Masahiro Yasui, Hiroyuki Fujisaki, Kazuko Hamamoto, Kana Washio, Hirotoshi Sakaguchi, (unknown), Yuko Osugi, Etsuko Nakagami‐Yamaguchi, (unknown), Atsushi Satō, Yoshiyuki Takahashi, Keizo Horibe	10
7	Intrathecal Infusion of Haploidentical Nondonor Lymphocytes for Central Nervous System Leukemic Relapse After Haploidentical Hematopoietic Stem Cell Transplantation 2017 ·Journal of Pediatric Hematology/Oncology ·(unknown), Akihisa Sawada, (unknown), (unknown), (unknown), Maho Sato, Masahiro Yasui, Masami Inoue	2
8	Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study 2016 ·International Journal of Hematology ·Akira Morimoto, Yoko Shioda, Toshihiko Imamura, Kazuko Kudo, Hiroshi Kawaguchi, Kazuo Sakashita, Masahiro Yasui, Yuhki Koga, Ryōji Kobayashi, Eiichi Ishii, Junichiro Fujimoto, Keizo Horibe, Fumio Bessho, Yukiko Tsunematsu, Shinsaku Imashuku	64
9	Feasibility of HLA-Haploidentical Hematopoietic Stem Cell Transplantation With Post-Transplantation Cyclophosphamide for Advanced Pediatric Malignancies 2014 ·Pediatric Hematology and Oncology ·Akihisa Sawada, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Osamu Kondo, (unknown), Masahiro Yasui, Keisei Kawa, Masami Inoue	29
10	HEMOLYTIC DISEASE OF THE NEWBORN IN INFANTS OF MOTHERS WITH IRREGULAR ANTIBODIES 2013 ·Japanese Journal of Transfusion and Cell Therapy ·(unknown), (unknown), Masahiro Yasui	1
11	Diet instructions to consume the allergenic foods based on the results of an oral food challenge test 2013 ·Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical Immunology ·(unknown), Naoyuki Kando, (unknown), Masahiro Yasui, Toru Maeda, (unknown), (unknown), Komei Ito	5
12	A survey of patients that had a prescription of an adrenalin auto-injector in our department 2013 ·Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical Immunology ·Masahiro Yasui, Asuka Hino, Toru Maeda, (unknown), (unknown), Naoyuki Kando, Komei Ito	1
13	Diet instructions to increase the tolerated dose in patients with positive egg challenge test results (2nd report) 2013 ·Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical Immunology ·(unknown), Naoyuki Kando, (unknown), Masahiro Yasui, Toru Maeda, Asuka Hino, (unknown), (unknown), Komei Ito	3
14	Multiplex polymerase chain reaction for six herpesviruses after hematopoietic stem cell transplantation 2011 ·Pediatrics International ·Akihisa Sawada, (unknown), Masahiro Yasui, Osamu Kondo, Takashi Ishihara, (unknown), Takayuki Okamura, Masanori Nishikawa, Masami Inoue, Keisei Kawa	6
15	Severe persistent bone marrow failure following therapy with 2‐chlorodeoxyadenosine for relapsing juvenile xanthogranuloma of the brain 2011 ·Pediatric Blood & Cancer ·K Yamada, Masahiro Yasui, Akihisa Sawada, Masami Inoue, Masahiro Nakayama, Keisei Kawa	16
16	NK-cell repertoire is feasible for diagnosing Epstein–Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect 2006 ·American Journal of Hematology ·Akihisa Sawada, Emiko Sato, (unknown), (unknown), (unknown), Ji Yoo Kim, (unknown), (unknown), Naoki Sakata, Takayuki Okamura, Masahiro Yasui, Masami Inoue, Keisei Kawa	11
17	Botryoid Wilms’ tumor of the renal pelvis extending into the bladder 2006 ·Urology ·Akira Nagahara, (unknown), Fumi Matsumoto, Akira Tohda, Kenji Shimada, Masahiro Yasui, Masami Inoue, Keisei Kawa, (unknown), (unknown)	14
18	Successful Treatment of Chemoresistant Stage 3 Neuroblastoma Using Irinotecan as a Single Agent 2005 ·Journal of Pediatric Hematology/Oncology ·Jiro Inagaki, Masahiro Yasui, Naoki Sakata, Masami Inoue, Keiko Yagi, Keisei Kawa	8
19	Autologous Hematopoietic Stem Cell Transplantation for 3 Patients with Severe Juvenile Rheumatoid Arthritis 2003 ·International Journal of Hematology ·(unknown), Takashi Hamazaki, Masahiro Yasui, (unknown), Takayuki Okamura, Naoki Sakata, Masami Inoue, Keiko Yagi, Keisei Kawa	6
20	Allogeneic hematopoietic stem cell transplantation for Epstein–Barr virus-associated T/NK-cell lymphoproliferative disease 2002 ·Critical Reviews in Oncology/Hematology ·Keisei Kawa, Takayuki Okamura, Masahiro Yasui, Emiko Sato, Masami Inoue	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact